Complicated Catheter-Associated Urinary Tract Infections Due to Escherichia coli and Proteus mirabilis

SUMMARY Catheter-associated urinary tract infections (CAUTIs) represent the most common type of nosocomial infection and are a major health concern due to the complications and frequent recurrence. These infections are often caused by Escherichia coli and Proteus mirabilis. Gram-negative bacterial species that cause CAUTIs express a number of virulence factors associated with adhesion, motility, biofilm formation, immunoavoidance, and nutrient acquisition as well as factors that cause damage to the host. These infections can be reduced by limiting catheter usage and ensuring that health care professionals correctly use closed-system Foley catheters. A number of novel approaches such as condom and suprapubic catheters, intermittent catheterization, new surfaces, catheters with antimicrobial agents, and probiotics have thus far met with limited success. While the diagnosis of symptomatic versus asymptomatic CAUTIs may be a contentious issue, it is generally agreed that once a catheterized patient is believed to have a symptomatic urinary tract infection, the catheter is removed if possible due to the high rate of relapse. Research focusing on the pathogenesis of CAUTIs will lead to a better understanding of the disease process and will subsequently lead to the development of new diagnosis, prevention, and treatment options.

[1]  I. Orskov,et al.  Serology, chemistry, and genetics of O and K antigens of Escherichia coli. , 1977, Bacteriological reviews.

[2]  A. Siitonen,et al.  Molecular epidemiology of 3 putative virulence genes for Escherichia coli urinary tract infection-usp, iha, and iroN(E. coli). , 2002, The Journal of infectious diseases.

[3]  R. Selvarangan,et al.  Decay-Accelerating Factor and Cytoskeleton Redistribution Pattern in HeLa Cells Infected with RecombinantEscherichia coli Strains Expressing Dr Family of Adhesins , 1999, Infection and Immunity.

[4]  R. Welch,et al.  Cytotoxic activity of the Proteus hemolysin HpmA , 1990, Infection and immunity.

[5]  G. Ulett,et al.  The role of F9 fimbriae of uropathogenic Escherichia coli in biofilm formation. , 2007, Microbiology.

[6]  R. Russell,et al.  Construction of an MR/P fimbrial mutant of Proteus mirabilis: role in virulence in a mouse model of ascending urinary tract infection , 1994, Infection and immunity.

[7]  D. Stickler,et al.  Complications of urinary tract infections associated with devices used for long-term bladder management. , 1994, The Journal of hospital infection.

[8]  G. Ducel [Nosocomial infections in the intensive care unit]. , 1987, Schweizerische medizinische Wochenschrift.

[9]  B. H. Şen,et al.  Ultrastructural stages of biofilm development of Escherichia coli on urethral catheters and effects of antibiotics on biofilm formation. , 2006, Urology.

[10]  E. Vinogradov,et al.  The structure of the carbohydrate backbone of the core-lipid A region of the lipopolysaccharide from Proteus vulgaris serotype O25. , 2000, Carbohydrate research.

[11]  R. Munasinghe,et al.  Appropriateness of Use of Indwelling Urinary Catheters in Patients Admitted to the Medical Service , 2001, Infection Control & Hospital Epidemiology.

[12]  M. Footer,et al.  Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[13]  S. Hultgren,et al.  Binding of Pili from UropathogenicEscherichia coli to Membranes Secreted by Human Colonocytes and Enterocytes , 1999, Infection and Immunity.

[14]  H. Mobley,et al.  Construction of a urease-negative mutant of Proteus mirabilis: analysis of virulence in a mouse model of ascending urinary tract infection , 1990, Infection and immunity.

[15]  M. Kerr,et al.  A proteolytic enzyme secreted by Proteus mirabilis degrades immunoglobulins of the immunoglobulin A1 (IgA1), IgA2, and IgG isotypes , 1990, Infection and immunity.

[16]  A. Schmidtchen,et al.  Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL‐37 , 2002, Molecular microbiology.

[17]  B. Harrison,et al.  The binding of Proteus mirabilis nonagglutinating fimbriae to ganglio-series asialoglycolipids and lactosyl ceramide. , 2000, Canadian journal of microbiology.

[18]  J. Nataro,et al.  Characterization of the AfaD‐like family of invasins encoded by pathogenic Escherichia coli associated with intestinal and extra‐intestinal infections , 2000, FEBS letters.

[19]  F. Orskov Virulence factors of the bacterial cell surface. , 1978, The Journal of infectious diseases.

[20]  G. Le Negrate,et al.  Escherichia coli cytotoxic necrotizing factor‐1 (CNF‐1) increases the adherence to epithelia and the oxidative burst of human polymorphonuclear leukocytes but decreases bacteria phagocytosis , 2000, Journal of leukocyte biology.

[21]  D. Musher,et al.  Progression from asymptomatic to symptomatic urinary tract infection in patients with SCI: a preliminary study. , 1993, The Journal of the American Paraplegia Society.

[22]  E. Weinberg Iron withholding: a defense against infection and neoplasia. , 1984, Physiological reviews.

[23]  H. Mobley,et al.  The IrgA Homologue Adhesin Iha Is an Escherichia coli Virulence Factor in Murine Urinary Tract Infection , 2005, Infection and Immunity.

[24]  M. Perry,et al.  The structure of the polysaccharide produced by Proteus vulgaris (ATCC 49990). , 1992, Carbohydrate research.

[25]  R. C. Stanley,et al.  Nosocomial infections in U.S. hospitals, 1975-1976: estimated frequency by selected characteristics of patients. , 1981, The American journal of medicine.

[26]  T. Elliott,et al.  The pathogenesis of urinary tract infections associated with Escherichia coli, Staphylococcus saprophyticus and S. epidermidis. , 1990, Journal of medical microbiology.

[27]  S. Langermann,et al.  Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination. , 1997, Science.

[28]  W. Stamm,et al.  Bacterial adherence to bladder uroepithelial cells in catheter-associated urinary tract infection. , 1986, The New England journal of medicine.

[29]  P. Taylor,et al.  A nosocomial outbreak of infections due to multiply resistant Proteus mirabilis: role of intestinal colonization as a major reservoir. , 1979, The Journal of infectious diseases.

[30]  S. Opal,et al.  Aerobactin and alpha-hemolysin as virulence determinants in Escherichia coli isolated from human blood, urine, and stool. , 1990, The Journal of infectious diseases.

[31]  Y. Knirel,et al.  Structural and immunochemical studies on the O-specific polysaccharide of Proteus penneri strain 15. , 1997, Archivum immunologiae et therapiae experimentalis.

[32]  L.,et al.  The cleavage of immunoglobulin G in vitro and in vivo by a proteinase secreted by the urinary tract pathogen Proteus mirabilis , 2022 .

[33]  A. Schaeffer,et al.  Relationship of type 1 pilus expression in Escherichia coli to ascending urinary tract infections in mice , 1987, Infection and immunity.

[34]  Hui Zhao,et al.  Visualization of Proteus mirabilis within the Matrix of Urease-Induced Bladder Stones during Experimental Urinary Tract Infection , 2002, Infection and Immunity.

[35]  C. Brinton The structure, function, synthesis and genetic control of bacterial pili and a molecular model for DNA and RNA transport in gram negative bacteria. , 1965, Transactions of the New York Academy of Sciences.

[36]  M. Fitzgerald,et al.  A Simplified Method for the Quantitative Bacterial Culture of Urine , 1960, Journal of clinical pathology.

[37]  F. Daschner Nosocomial infections in intensive care units , 1990, Intensive Care Medicine.

[38]  R Möllby,et al.  Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli. , 2000, The Journal of infectious diseases.

[39]  D. Stickler,et al.  Bacterial biofilms and the encrustation of urethral catheters , 1996 .

[40]  R. Kolter,et al.  Biofilm formation as a developmental process. , 2001, Methods in Enzymology.

[41]  G. Bitton,et al.  Adsorption of microorganisms to surfaces. , 1980 .

[42]  D. Rasko,et al.  Repression of bacterial motility by a novel fimbrial gene product , 2001, The EMBO journal.

[43]  G. Fraser,et al.  Swarming-coupled expression of the Proteus mirabilis hpmBA haemolysin operon. , 2002, Microbiology.

[44]  F. Albright,et al.  Dissolution of Phosphatic Urinary Calculi by the Retrograde Introduction of a Citrate Solution Containing Magnesium , 1943 .

[45]  I S Roberts,et al.  Structure, assembly and regulation of expression of capsules in Escherichia coli , 1999, Molecular microbiology.

[46]  E. Vinogradov,et al.  Structural analysis of the core region of lipopolysaccharides from Proteus mirabilis serotypes O6, O48 and O57. , 2000, European journal of biochemistry.

[47]  E. Evans Indwelling catheter care: dispelling the misconceptions. , 1999, Geriatric nursing.

[48]  C. Winters,et al.  Blockage of urethral catheters by bacterial biofilms. , 1993, The Journal of infection.

[49]  H. Mobley,et al.  Proteus mirabilis urease: genetic organization, regulation, and expression of structural genes , 1988, Journal of bacteriology.

[50]  J. Kur,et al.  Molecular Aspects of Biogenesis of Escherichia coli Dr Fimbriae: Characterization of DraB-DraE Complexes , 2005, Infection and Immunity.

[51]  V. Thomas,et al.  Identification of UreR binding sites in the Enterobacteriaceae plasmid‐encoded and Proteus mirabilis urease gene operons , 1999, Molecular microbiology.

[52]  Structure of a 2-aminoethyl phosphate-containing O-specific polysaccharide of Proteus penneri 63 from a new serogroup O68: O-specific polysaccharide of Proteus penneri 63 , 2000 .

[53]  B. Trautner,et al.  Prevention of catheter-associated urinary tract infection , 2005, Current opinion in infectious diseases.

[54]  Sarah Cope,et al.  Using silver to reduce catheter-associated urinary tract infections. , 2005, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[55]  T. Hooton,et al.  Management of urinary tract infections in adults. , 1993, The New England journal of medicine.

[56]  R. Spencer,et al.  Evaluation of six screening methods for detecting significant bacteriuria. , 1988, Journal of clinical pathology.

[57]  M. Donnenberg,et al.  Internalization of Escherichia coli by human renal epithelial cells is associated with tyrosine phosphorylation of specific host cell proteins , 1997, Infection and immunity.

[58]  P. Dasgupta,et al.  Urinary tract infections: new insights into a common problem , 2005, Postgraduate Medical Journal.

[59]  P. Griffiths,et al.  Preventing blockage of long-term indwelling catheters in adults: are citric acid solutions effective? , 2003, British journal of community nursing.

[60]  H. Lai,et al.  Cell differentiation of Proteus mirabilis is initiated by glutamine, a specific chemoattractant for swarming cells , 1993, Molecular microbiology.

[61]  J. Elmore,et al.  Urological Survey: Abstracts: Urinary Tract InfectionThe Efficacy of Silver Alloy-Coated Urinary Catheters in Preventing Urinary Tract Infection: A Meta-Analysis , 1999 .

[62]  R. Belas,et al.  Genetic analysis of Proteus mirabilis mutants defective in swarmer cell elongation , 1995, Journal of bacteriology.

[63]  H. Mobley,et al.  Internalization of Escherichia coli into human renal tubular epithelial cells. , 1988, The Journal of infectious diseases.

[64]  P. Tambyah,et al.  Engineering out the risk for infection with urinary catheters. , 2001, Emerging infectious diseases.

[65]  S. Payne,et al.  Iron and virulence in the family Enterobacteriaceae. , 1988, Critical reviews in microbiology.

[66]  R. Hausinger,et al.  Proteus mirabilis urease. Partial purification and inhibition by boric acid and boronic acids. , 1988, The Biochemical journal.

[67]  J. R. Johnson,et al.  Molecular Epidemiological and Phylogenetic Associations of Two Novel Putative Virulence Genes, iha and iroNE. coli, among Escherichia coli Isolates from Patients with Urosepsis , 2000, Infection and Immunity.

[68]  S. Falkow,et al.  Construction and expression of recombinant plasmids encoding type 1 or D-mannose-resistant pili from a urinary tract infection Escherichia coli isolate , 1981, Infection and immunity.

[69]  Stefan Wuertz,et al.  High Rates of Conjugation in Bacterial Biofilms as Determined by Quantitative In Situ Analysis , 1999, Applied and Environmental Microbiology.

[70]  H. Mobley,et al.  Differential regulation of the Proteus mirabilis urease gene cluster by UreR and H-NS. , 2003, Microbiology.

[71]  V. Regueiro,et al.  Capsule Polysaccharide Mediates Bacterial Resistance to Antimicrobial Peptides , 2004, Infection and Immunity.

[72]  A. Jönsson,et al.  The importance of osmolality for intermittent catheterization of the urethra , 2000, Spinal Cord.

[73]  J. Bullen The significance of iron in infection. , 1981, Reviews of infectious diseases.

[74]  C. Hughes,et al.  Production and properties of haemolysins from clinical isolates of the Proteeae. , 1988, Journal of medical microbiology.

[75]  H. Mobley,et al.  Cytotoxicity of the HpmA hemolysin and urease of Proteus mirabilis and Proteus vulgaris against cultured human renal proximal tubular epithelial cells , 1991, Infection and immunity.

[76]  Y. Knirel,et al.  Structure of the O-specific polysaccharide of Proteus penneri 62 containing 2-acetamido-3-O-[(S)-1-carboxyethyl]-2-deoxy-D-glucose (N-acetylisomuramic acid). , 1992, Carbohydrate research.

[77]  C. B. Smith,et al.  Meatal colonization and catheter-associated bacteriuria. , 1980, The New England journal of medicine.

[78]  P. Tambyah,et al.  A prospective study of pathogenesis of catheter-associated urinary tract infections. , 1999, Mayo Clinic proceedings.

[79]  A. Różalski,et al.  Hemolytic activity and invasiveness in strains of Proteus penneri , 1987, Journal of clinical microbiology.

[80]  R. Suvanasuthi,et al.  The Ability of Proteus mirabilis To Sense Surfaces and Regulate Virulence Gene Expression Involves FliL, a Flagellar Basal Body Protein , 2005, Journal of bacteriology.

[81]  M. Perry,et al.  Capsule structure of Proteus mirabilis (ATCC 49565) , 1992, Journal of bacteriology.

[82]  J. R. Johnson,et al.  Virulence factors in Escherichia coli urinary tract infection , 1991, Clinical Microbiology Reviews.

[83]  K. Kotełko,et al.  Proteus mirabilis: taxonomic position, peculiarities of growth, components of the cell envelope. , 1986, Current topics in microbiology and immunology.

[84]  D. Musher,et al.  Urease. The primary cause of infection-induced urinary stones. , 1976, Investigative urology.

[85]  H. Mobley,et al.  Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains , 1990, Infection and immunity.

[86]  M. Kagayama,et al.  An electron microscopic study of the interaction between vesical epitherlium and E. Coli. , 1979, Investigative urology.

[87]  H. Mobley,et al.  Proteus mirabilis MR/P fimbrial operon: genetic organization, nucleotide sequence, and conditions for expression , 1994, Journal of bacteriology.

[88]  M. Mulvey,et al.  Adhesion and entry of uropathogenic Escherichia coli , 2002, Cellular microbiology.

[89]  Kshitij D Modi,et al.  Noninvasive Biophotonic Imaging for Monitoring of Catheter-Associated Urinary Tract Infections and Therapy in Mice , 2005, Infection and Immunity.

[90]  M. Rosenheim MANDELIC ACID IN THE TREATMENT OF URINARY INFECTIONS , 1935 .

[91]  C. Osborne,et al.  Infection (urease) stones. , 1987, Mineral and electrolyte metabolism.

[92]  R. M. Donlan,et al.  Biofilms and device-associated infections. , 2001, Emerging infectious diseases.

[93]  B. Saxon,et al.  Use of the Bac-T-Screen to predict bacteriuria from urine specimens held at room temperature , 1986, Journal of clinical microbiology.

[94]  G. Reid,et al.  Effects of ciprofloxacin, norfloxacin, and ofloxacin on in vitro adhesion and survival of Pseudomonas aeruginosa AK1 on urinary catheters , 1994, Antimicrobial Agents and Chemotherapy.

[95]  A. Schaeffer Pilot Trial of Bacterial Interference for Preventing Urinary Tract Infection , 2002 .

[96]  J. Burke,et al.  Antimicrobial Prophylaxis for Catheter-Associated Bacteriuria , 1977, Antimicrobial Agents and Chemotherapy.

[97]  T. Lam,et al.  Types of urethral catheters for management of short-term voiding problems in hospitalised adults. , 2008, The Cochrane database of systematic reviews.

[98]  P. Rather Swarmer cell differentiation in Proteus mirabilis. , 2005, Environmental microbiology.

[99]  R. Russell,et al.  Contribution of Proteus mirabilis urease to persistence, urolithiasis, and acute pyelonephritis in a mouse model of ascending urinary tract infection , 1993, Infection and immunity.

[100]  J. Costerton,et al.  Introduction to biofilm. , 1999, International journal of antimicrobial agents.

[101]  Eshwar Mahenthiralingam,et al.  Ultrastructure of Proteus mirabilis Swarmer Cell Rafts and Role of Swarming in Catheter-Associated Urinary Tract Infection , 2004, Infection and Immunity.

[102]  W. Donovan,et al.  Pilot trial of bacterial interference for preventing urinary tract infection. , 2001, Urology.

[103]  R. Hull,et al.  Molecular cloning of Proteus mirabilis uroepithelial cell adherence (uca) genes , 1995, Infection and immunity.

[104]  J. Brisson,et al.  Application of 1D and 2D NMR techniques to the structure elucidation of the O-polysaccharide from Proteus mirabilis O: 57 , 1994, Journal of biomolecular NMR.

[105]  V. Thomas,et al.  Activation of transcription at divergent urea‐dependent promoters by the urease gene regulator UreR , 1996, Molecular microbiology.

[106]  E. Mahenthiralingam,et al.  Genotyping demonstrates that the strains of Proteus mirabilis from bladder stones and catheter encrustations of patients undergoing long-term bladder catheterization are identical. , 2004, The Journal of urology.

[107]  D. Stickler,et al.  Why are Foley catheters so vulnerable to encrustation and blockage by crystalline bacterial biofilm? , 2003, Urological Research.

[108]  J. Hebel,et al.  Internalization of Escherichia coli into human kidney epithelial cells: comparison of fecal and pyelonephritis-associated strains. , 1994, The Journal of infectious diseases.

[109]  H. Mobley,et al.  Proteus mirabilis urease: operon fusion and linker insertion analysis of ure gene organization, regulation, and function , 1995, Journal of bacteriology.

[110]  A. J. Cox Comparison of catheter surface morphologies. , 1990, British journal of urology.

[111]  William C Maxted,et al.  Urinalysis: a comprehensive review. , 2005, American family physician.

[112]  Craig A. Umscheid,et al.  Guideline for Prevention of Catheter-Associated Urinary Tract Infections 2009 , 2010, Infection Control & Hospital Epidemiology.

[113]  Michael P. Sheetz,et al.  Pilus retraction powers bacterial twitching motility , 2000, Nature.

[114]  H. Lai,et al.  Co‐ordinate expression of virulence genes during swarm‐cell differentiation and population migration of Proteus mirabilis , 1992, Molecular microbiology.

[115]  S. Hultgren,et al.  Role of intestinal surfactant-like particles as a potential reservoir of uropathogenic Escherichia coli. , 2000, Biochimica et biophysica acta.

[116]  M. Schembri,et al.  FimH‐mediated autoaggregation of Escherichia coli , 2001, Molecular microbiology.

[117]  B. Hess,et al.  Pathophysiologie, Diagnostik und konservative Therapie bei nicht-kalziumhaltigen Nierensteinen , 2003 .

[118]  M. Kerr,et al.  A survey of IgA protease production among clinical isolates of Proteeae. , 1988, Journal of medical microbiology.

[119]  A. Różalski,et al.  Characterization of cell-bound and cell-free hemolytic activity of proteus strains , 1991, European Journal of Epidemiology.

[120]  J. Penner,et al.  Separate O-grouping schemes for serotyping clinical isolates of Proteus vulgaris and Proteus mirabilis , 1980, Journal of clinical microbiology.

[121]  S. Saint Clinical and economic consequences of nosocomial catheter-related bacteriuria. , 2000, American journal of infection control.

[122]  H. Mobley,et al.  Proteus mirabilis Genes That Contribute to Pathogenesis of Urinary Tract Infection: Identification of 25 Signature-Tagged Mutants Attenuated at Least 100-Fold , 2004, Infection and Immunity.

[123]  C. B. Smith,et al.  Factors predisposing to bacteriuria during indwelling urethral catheterization. , 1975, The New England journal of medicine.

[124]  A. Hesse,et al.  Chemolitholysis and Lithotripsy of Infectious Urinary Stones – An in vitro Study , 2002, Urologia Internationalis.

[125]  D. Musher,et al.  Role of urease in pyelonephritis resulting from urinary tract infection with Proteus. , 1975, The Journal of infectious diseases.

[126]  R. Schwarzhoff,et al.  Nature of the swarming phenomenon in Proteus. , 1978, Annual review of microbiology.

[127]  H. Mobley,et al.  Proteus mirabilis mannose-resistant, Proteus-like fimbriae: MrpG is located at the fimbrial tip and is required for fimbrial assembly , 1997, Infection and immunity.

[128]  T. Wilt,et al.  Systematic Review: Antimicrobial Urinary Catheters To Prevent Catheter-Associated Urinary Tract Infection in Hospitalized Patients , 2006, Annals of Internal Medicine.

[129]  T. Möttönen,et al.  P fimbria-specific B cell responses in patients with urinary tract infection. , 2003, The Journal of infectious diseases.

[130]  M. Regué,et al.  The inner-core lipopolysaccharide biosynthetic waaE gene: function and genetic distribution among some Enterobacteriaceae. , 2002, Microbiology.

[131]  S. Hultgren,et al.  Bacterial pili: molecular mechanisms of pathogenesis. , 2000, Current opinion in microbiology.

[132]  U. Seydel,et al.  Lipid-Specific Membrane Activity of Human β-Defensin-3† , 2006 .

[133]  B. Jones,et al.  Role of swarming in the formation of crystalline Proteus mirabilis biofilms on urinary catheters. , 2005, Journal of medical microbiology.

[134]  D. Maskell,et al.  Virulence of a Proteus mirabilis ATF isogenic mutant is not impaired in a mouse model of ascending urinary tract infection. , 2000, FEMS immunology and medical microbiology.

[135]  W. Anthony,et al.  A prospective microbiologic study of bacteriuria in patients with chronic indwelling urethral catheters. , 1982, The Journal of infectious diseases.

[136]  R. Welch Pore‐forming cytolysins of Gram‐negative bacteria , 1991, Molecular microbiology.

[137]  Jona Zumeris,et al.  Effective Prevention of Microbial Biofilm Formation on Medical Devices by Low-Energy Surface Acoustic Waves , 2006, Antimicrobial Agents and Chemotherapy.

[138]  H. Mobley,et al.  Proteus mirabilis amino acid deaminase: cloning, nucleotide sequence, and characterization of aad , 1995, Journal of bacteriology.

[139]  B. Trautner,et al.  Role of biofilm in catheter-associated urinary tract infection. , 2004, American journal of infection control.

[140]  A. Torzewska,et al.  Crystallization of urine mineral components may depend on the chemical nature of Proteus endotoxin polysaccharides. , 2003, Journal of medical microbiology.

[141]  V. Braun,et al.  Pore-forming bacterial protein hemolysins (cytolysins). , 1991, Critical reviews in microbiology.

[142]  D. E. Bradley A function of Pseudomonas aeruginosa PAO polar pili: twitching motility. , 1980, Canadian journal of microbiology.

[143]  J. Hacker,et al.  Pathogenicity islands and the evolution of microbes. , 2000, Annual review of microbiology.

[144]  J. Chawla,et al.  Virulence factors in Escherichia coli from urinary tract infections in patients with spinal injuries. , 1992, The Journal of hospital infection.

[145]  H. Mobley,et al.  Requirement of MrpH for Mannose-ResistantProteus-Like Fimbria-Mediated Hemagglutination byProteus mirabilis , 1999, Infection and Immunity.

[146]  M. T. Beck,et al.  Down-Regulation of the kps Region 1 Capsular Assembly Operon following Attachment of Escherichia coli Type 1 Fimbriae to d-Mannose Receptors , 2005, Infection and Immunity.

[147]  H. Mobley,et al.  Urinary tract infections : molecular pathogenesis and clinical management , 1996 .

[148]  M. Kerr,et al.  The production and activity in vivo of Proteus mirabilis IgA protease in infections of the urinary tract. , 1991, Journal of medical microbiology.

[149]  S. Kjelleberg,et al.  Do marine natural products interfere with prokaryotic AHL regulatory systems , 1997 .

[150]  R. Belas,et al.  Sequence and genetic analysis of multiple flagellin-encoding genes from Proteus mirabilis. , 1994, Gene.

[151]  T. Russo,et al.  IroN Functions as a Siderophore Receptor and Is a Urovirulence Factor in an Extraintestinal Pathogenic Isolate of Escherichia coli , 2002, Infection and Immunity.

[152]  İ. Kaleli,et al.  Production by Escherichia coli isolates of siderophore and other virulence factors and their pathogenic role in a cutaneous infection model. , 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[153]  C. Bloch,et al.  Virulence characteristics of Escherichia coli causing first urinary tract infection predict risk of second infection. , 1995, The Journal of infectious diseases.

[154]  D. Classen,et al.  A large randomized clinical trial of a silver-impregnated urinary catheter: lack of efficacy and staphylococcal superinfection. , 1995, The American journal of medicine.

[155]  H. Mobley,et al.  Role of Motility in the Colonization of Uropathogenic Escherichia coli in the Urinary Tract , 2005, Infection and Immunity.

[156]  L. Emödy,et al.  The role of swarm cell differentiation and multicellular migration in the uropathogenicity of Proteus mirabilis. , 1994, The Journal of infectious diseases.

[157]  G. O’Toole,et al.  Microbial Biofilms: from Ecology to Molecular Genetics , 2000, Microbiology and Molecular Biology Reviews.

[158]  Limin Zheng,et al.  Uropathogenic Escherichia coli Triggers Oxygen-Dependent Apoptosis in Human Neutrophils through the Cooperative Effect of Type 1 Fimbriae and Lipopolysaccharide , 2004, Infection and Immunity.

[159]  C. Svanborg,et al.  Intestinal carriage of P fimbriated Escherichia coli and the susceptibility to urinary tract infection in young children. , 1995, The Journal of infectious diseases.

[160]  W. Hörl,et al.  Common errors in diagnosis and management of urinary tract infection. II: clinical management. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[161]  W. Stamm,et al.  Prevention of catheter-associated urinary tract infection with a silver oxide-coated urinary catheter: clinical and microbiologic correlates. , 1990, The Journal of infectious diseases.

[162]  A. Camilli,et al.  Detection and analysis of gene expression during infection by in vivo expression technology. , 2000, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[163]  Harry L. T. Mobley,et al.  Sat, the Secreted Autotransporter Toxin of Uropathogenic Escherichia coli, Is a Vacuolating Cytotoxin for Bladder and Kidney Epithelial Cells , 2002, Infection and Immunity.

[164]  Carlene A. Muto,et al.  A randomized crossover study of silver-coated urinary catheters in hospitalized patients. , 2000, Archives of internal medicine.

[165]  P. Urvil,et al.  Dr Operon-Associated Invasiveness ofEscherichia coli from Pregnant Patients with Pyelonephritis , 2001, Infection and Immunity.

[166]  K. Hantke,et al.  Functions of the siderophore esterases IroD and IroE in iron-salmochelin utilization. , 2005, Microbiology.

[167]  R. Crow,et al.  Bacteriuria during indwelling urethral catheterization. , 1988, The Journal of hospital infection.

[168]  Hongjian Liu,et al.  Identification of Proteus mirabilisMutants with Increased Sensitivity to Antimicrobial Peptides , 2001, Antimicrobial Agents and Chemotherapy.

[169]  A. N. Kondakova,et al.  Structure of the neutral O-polysaccharide and biological activities of the lipopolysaccharide of Proteus mirabilis O20. , 2004, Carbohydrate research.

[170]  H. Mobley,et al.  Identification of MrpI as the sole recombinase that regulates the phase variation of MR/P fimbria, a bladder colonization factor of uropathogenic Proteus mirabilis , 2002, Molecular microbiology.

[171]  P. Thibault,et al.  Galectin-3-mediated adherence of Proteus mirabilis to Madin-Darby canine kidney cells. , 2001, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[172]  E. Vinogradov,et al.  The structure and serological specificity of Proteus mirabilis O43 O antigen. , 1995, European journal of biochemistry.

[173]  P. Scardino,et al.  Efficacy of antimicrobial-impregnated bladder catheters in reducing catheter-associated bacteriuria: a prospective, randomized, multicenter clinical trial. , 1999, Urology.

[174]  H. Mobley,et al.  Proteus mirabilis flagella and MR/P fimbriae: isolation, purification, N-terminal analysis, and serum antibody response following experimental urinary tract infection , 1991, Infection and immunity.

[175]  F. Nowrouzian,et al.  Enhanced persistence in the colonic microbiota of Escherichia coli strains belonging to phylogenetic group B2: role of virulence factors and adherence to colonic cells. , 2006, Microbes and infection.

[176]  A. N. Kondakova,et al.  Structure of the O-polysaccharide of a serologically separate strain of Proteus mirabilis, TG 332, from a new proposed Proteus serogroup O50. , 2003, Carbohydrate research.

[177]  Scott J. Hultgren,et al.  Functional Genomic Studies of Uropathogenic Escherichia coli and Host Urothelial Cells when Intracellular Bacterial Communities Are Assembled* , 2007, Journal of Biological Chemistry.

[178]  H. Mobley,et al.  Proteus mirabilis fimbriae: N-terminal amino acid sequence of a major fimbrial subunit and nucleotide sequences of the genes from two strains , 1993, Infection and immunity.

[179]  Robert B. Simmons,et al.  Effects of silver on adherence of bacteria to urinary catheters: In vitro studies , 2004, Current Microbiology.

[180]  J. Gates,et al.  Urinary tract infection in surgical patients. , 2003, American journal of surgery.

[181]  J. Nickel,et al.  The ecology and pathogenicity of urease-producing bacteria in the urinary tract. , 1988, Critical reviews in microbiology.

[182]  O. Gofrit,et al.  Complete staghorn calculi: random prospective comparison between extracorporeal shock wave lithotripsy monotherapy and combined with percutaneous nephrostolithotomy. , 1997, The Journal of urology.

[183]  W. Donovan,et al.  Urinary tract infection prophylaxis using Escherichia coli 83972 in spinal cord injured patients. , 2000, The Journal of urology.

[184]  R. Suvanasuthi,et al.  Proteus mirabilis ZapA Metalloprotease Degrades a Broad Spectrum of Substrates, Including Antimicrobial Peptides , 2004, Infection and Immunity.

[185]  J. Lawrence,et al.  Proteus mirabilis biofilm protection against struvite crystal dissolution and its implications in struvite urolithiasis. , 1991, The Journal of urology.

[186]  E. Vinogradov,et al.  The structure of the O-specific polysaccharide chain of Proteus penneri strain 16 lipopolysaccharide. , 1991, European journal of biochemistry.

[187]  A. Jansen,et al.  Visualization of Proteus mirabilis Morphotypes in the Urinary Tract: the Elongated Swarmer Cell Is Rarely Observed in Ascending Urinary Tract Infection , 2003, Infection and Immunity.

[188]  R. Kolter,et al.  Genetic analysis of Escherichia coli biofilm formation: roles of flagella, motility, chemotaxis and type I pili , 1998, Molecular microbiology.

[189]  Structure of a 2-aminoethyl phosphate-containing O-specific polysaccharide of Proteus penneri 63 from a new serogroup O68. , 2000, European journal of biochemistry.

[190]  James R. Anderson,et al.  Effect of silver-coated urinary catheters: efficacy, cost-effectiveness, and antimicrobial resistance. , 2004, American journal of infection control.

[191]  W. Stamm,et al.  Urinary tract infections in women: diagnosis and treatment. , 1989, Annals of internal medicine.

[192]  S. Hultgren,et al.  Bacterial Invasion Augments Epithelial Cytokine Responses to Escherichia coli Through a Lipopolysaccharide-Dependent Mechanism1 , 2001, The Journal of Immunology.

[193]  R. Powell,et al.  Crystallization and preliminary X-ray diffraction analysis of a biologically active fragment of CD55. , 1999, Acta crystallographica. Section D, Biological crystallography.

[194]  R. Hausinger,et al.  Copyright � 1995, American Society for Microbiology Molecular Biology of Microbial Ureases , 1995 .

[195]  T. Kirikae,et al.  Bacterial endotoxin: molecular relationships of structure to activity and function , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[196]  H. Mobley,et al.  Proteus mirabilis fimbriae: identification, isolation, and characterization of a new ambient-temperature fimbria , 1994, Infection and immunity.

[197]  R. Belas Expression of multiple flagellin-encoding genes of Proteus mirabilis , 1994, Journal of bacteriology.

[198]  D. Cravens,et al.  Urinary catheter management. , 2000, American family physician.

[199]  J. Gunn Bacterial modification of LPS and resistance to antimicrobial peptides , 2001, Journal of endotoxin research.

[200]  J. Lingeman,et al.  Evolution of the technique of combination therapy for staghorn calculi: a decreasing role for extracorporeal shock wave lithotripsy. , 1992, The Journal of urology.

[201]  J. Pinkner,et al.  Type 1 pilus‐mediated bacterial invasion of bladder epithelial cells , 2000, The EMBO journal.

[202]  J. Roberts,et al.  Bacterial adherence to urethral catheters. , 1990, The Journal of urology.

[203]  E. Vinogradov,et al.  Structural studies on the fucosamine-containing O-specific polysaccharide of Proteus vulgaris O19. , 1989, European journal of biochemistry.

[204]  C. Bryan,et al.  Hospital-acquired bacteremic urinary tract infection: epidemiology and outcome. , 1984, The Journal of urology.

[205]  I. Henderson,et al.  PicU, a second serine protease autotransporter of uropathogenic Escherichia coli. , 2004, FEMS microbiology letters.

[206]  R. Podschun,et al.  Klebsiella spp. as Nosocomial Pathogens: Epidemiology, Taxonomy, Typing Methods, and Pathogenicity Factors , 1998, Clinical Microbiology Reviews.

[207]  W. Rabsch,et al.  Further differentiation of Enterobacteriaceae by means of siderophore-pattern analysis. , 1988, Zentralblatt fur Bakteriologie, Mikrobiologie, und Hygiene. Series A, Medical microbiology, infectious diseases, virology, parasitology.

[208]  R. Carlson,et al.  The structure of the colony migration factor from pathogenic Proteus mirabilis. A capsular polysaccharide that facilitates swarming. , 1999, The Journal of biological chemistry.

[209]  B. Trautner,et al.  Colicins prevent colonization of urinary catheters. , 2005, The Journal of antimicrobial chemotherapy.

[210]  R. Cook,et al.  Identification and characterization of a uroepithelial cell adhesin from a uropathogenic isolate of Proteus mirabilis , 1986, Infection and Immunity.

[211]  W. Goebel,et al.  Contribution of cloned virulence factors from uropathogenic Escherichia coli strains to nephropathogenicity in an experimental rat pyelonephritis model , 1986, Infection and immunity.

[212]  H. Mayer,et al.  Properties of a deep Proteus R mutant isolated from clinical material , 1991, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[213]  F. Ørskov Virulence Factors of the Bacterial Cell Surface , 1978 .

[214]  P. Lambert,et al.  The role of the O and K antigens in determining the resistance of Klebsiella aerogenes to serum killing and phagocytosis. , 1983, Journal of general microbiology.

[215]  J. Hacker,et al.  Receptor Structure for F1C Fimbriae of Uropathogenic Escherichia coli , 2000, Infection and Immunity.

[216]  R. Belas,et al.  Detection and mutation of a luxS-encoded autoinducer in Proteus mirabilis. , 2002, Microbiology.

[217]  C. Fuqua,et al.  Biofilms on Indwelling Urethral Catheters Produce Quorum-Sensing Signal Molecules In Situ and In Vitro , 1998, Applied and Environmental Microbiology.

[218]  R. Marcus Narrow-bore suprapubic bladder drainage in Uganda. , 1967, Lancet.

[219]  H. Mobley,et al.  H-NS Is a Repressor of the Proteus mirabilis Urease Transcriptional Activator GeneureR , 2000, Journal of bacteriology.

[220]  S. Langermann,et al.  Vaccination utilizing the FimCH complex as a strategy to prevent Escherichia coli urinary tract infections. , 2001, The Journal of infectious diseases.

[221]  T. Kirikae,et al.  Biological activities of lipopolysaccharides of Proteus spp. and their interactions with polymyxin B and an 18-kDa cationic antimicrobial protein (CAP18)-derived peptide. , 2000, Journal of medical microbiology.

[222]  R. Belas,et al.  Construction of a flagellum-negative mutant of Proteus mirabilis: effect on internalization by human renal epithelial cells and virulence in a mouse model of ascending urinary tract infection , 1996, Infection and immunity.

[223]  P. Stanley,et al.  Acylation of Escherichia coli Hemolysin: A Unique Protein Lipidation Mechanism Underlying Toxin Function , 1998, Microbiology and Molecular Biology Reviews.

[224]  R. Russell,et al.  Comparison of Escherichia coli strains recovered from human cystitis and pyelonephritis infections in transurethrally challenged mice. , 1999, Infection and immunity.

[225]  P Jain,et al.  Overuse of the indwelling urinary tract catheter in hospitalized medical patients. , 1995, Archives of internal medicine.

[226]  H. Mobley,et al.  Cloning of urease gene sequences from Providencia stuartii , 1986, Infection and immunity.

[227]  C. Hennekens,et al.  Prevention of catheter-associated urinary tract infection. An additional measure. , 1972, JAMA.

[228]  E. Vinogradov,et al.  Structure of the 0-specific polysaccharide of Proteus mirabilis S 1959. , 1987, Archivum immunologiae et therapiae experimentalis.

[229]  D. Hukins,et al.  Feasability of Preventing Encrustation of Urinary Catheters , 1995 .

[230]  D. Eto,et al.  Covert Operations of Uropathogenic Escherichia coli within the Urinary Tract , 2005, Traffic.

[231]  M. Kerr,et al.  The cleavage of immunoglobulin G in vitro and in vivo by a proteinase secreted by the urinary tract pathogen Proteus mirabilis. , 1993, Journal of medical microbiology.

[232]  S. Hultgren,et al.  Toll-like receptor 4 on stromal and hematopoietic cells mediates innate resistance to uropathogenic Escherichia coli , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[233]  H. Mobley,et al.  Genetic organization and complete sequence of the Proteus mirabilis pmf fimbrial operon. , 1994, Gene.

[234]  J. Tenney,et al.  MR/K hemagglutination of Providencia stuartii correlates with adherence to catheters and with persistence in catheter-associated bacteriuria. , 1988, The Journal of infectious diseases.

[235]  M. Kerr,et al.  Proteus mirabilis strains of diverse type have IgA protease activity. , 1987, Journal of medical microbiology.

[236]  B. J. Hinnebusch,et al.  Depolymerization of β-1,6-N-Acetyl-d-Glucosamine Disrupts the Integrity of Diverse Bacterial Biofilms , 2005, Journal of bacteriology.

[237]  V. Koronakis,et al.  Identification of the promotors directing in vivo expression of hemolysin genes in Proteus vulgaris and Escherichia coli , 1988, Molecular and General Genetics MGG.

[238]  C. Wandersman,et al.  Cloning, nucleotide sequence and characterization of the gene encoding the Erwinia chrysanthemi B374 PrtA metalloprotease: a third metalloprotease secreted via a C-terminal secretion signal , 1992, Molecular and General Genetics MGG.

[239]  R. Adegbola,et al.  Haemagglutinins and fimbriae of Morganella, Proteus and Providencia. , 1982, Journal of medical microbiology.

[240]  B. Harrison,et al.  The expression of nonagglutinating fimbriae and its role in Proteus mirabilis adherence to epithelial cells. , 1997, Canadian journal of microbiology.

[241]  V. Koronakis,et al.  The secreted hemolysins of Proteus mirabilis, Proteus vulgaris, and Morganella morganii are genetically related to each other and to the alpha-hemolysin of Escherichia coli , 1987, Journal of Bacteriology.

[242]  P. Barrow,et al.  Enterobacteriaceae , 2008, Poultry Diseases.

[243]  C. Kunin Detection, Prevention, and Management of Urinary Tract Infections , 1979 .

[244]  W. Dunne,et al.  Bacterial Adhesion: Seen Any Good Biofilms Lately? , 2002, Clinical Microbiology Reviews.

[245]  S. Gorman,et al.  Biofilm and biofilm-related encrustation of urinary tract devices. , 1999, Methods in Enzymology.

[246]  J. Priestley,et al.  Branched renal calculi. , 1949, The Journal of urology.

[247]  R. Welch Identification of two different hemolysin determinants in uropathogenic Proteus isolates , 1987, Infection and immunity.

[248]  T. Habuchi,et al.  Distribution and genetic association of putative uropathogenic virulence factors iroN, iha, kpsMT, ompT and usp in Escherichia coli isolated from urinary tract infections in Japan. , 2003, The Journal of urology.

[249]  K. K. Lai,et al.  Use of silver-hydrogel urinary catheters on the incidence of catheter-associated urinary tract infections in hospitalized patients. , 2002, American journal of infection control.

[250]  H. Mobley,et al.  Internalization of Proteus mirabilis by human renal epithelial cells , 1994, Infection and immunity.

[251]  S. Hultgren,et al.  CD14- and Toll-Like Receptor-Dependent Activation of Bladder Epithelial Cells by Lipopolysaccharide and Type 1 Piliated Escherichia coli , 2003, Infection and Immunity.

[252]  E. Greenberg,et al.  A component of innate immunity prevents bacterial biofilm development , 2002, Nature.

[253]  A. Diokno,et al.  Patient satisfaction and the LoFric catheter for clean intermittent catheterization. , 1995, The Journal of urology.

[254]  B. Trautner,et al.  Escherichia coli 83972 inhibits catheter adherence by a broad spectrum of uropathogens. , 2003, Urology.

[255]  H. Mobley,et al.  Transcriptome of Uropathogenic Escherichia coli during Urinary Tract Infection , 2004, Infection and Immunity.

[256]  D. MacLaren,et al.  Vero cell invasiveness of Proteus mirabilis , 1984, Infection and immunity.

[257]  M. Waters,et al.  A Sensor To Detect the Early Stages in the Development of Crystalline Proteus mirabilis Biofilm on Indwelling Bladder Catheters , 2006, Journal of Clinical Microbiology.

[258]  H. Mobley,et al.  Use of Translational Fusion of the MrpH Fimbrial Adhesin-Binding Domain with the Cholera Toxin A2 Domain, Coexpressed with the Cholera Toxin B Subunit, as an Intranasal Vaccine To Prevent Experimental Urinary Tract Infection by Proteus mirabilis , 2004, Infection and Immunity.

[259]  W. Thomas,et al.  The synthesis and function of the Escherichia coli hemolysin and related RTX exotoxins. , 1992, FEMS microbiology immunology.

[260]  J W Warren,et al.  Fever, bacteremia, and death as complications of bacteriuria in women with long-term urethral catheters. , 1987, The Journal of infectious diseases.

[261]  L. Truong,et al.  Development of experimental model of chronic pyelonephritis with Escherichia coli O75:K5:H-bearing Dr fimbriae: mutation in the dra region prevented tubulointerstitial nephritis. , 1997, The Journal of clinical investigation.

[262]  J. Kur,et al.  A surface-exposed DraD protein of uropathogenic Escherichia coli bearing Dr fimbriae may be expressed and secreted independently from DraC usher and DraE adhesin. , 2005, Microbiology.

[263]  J. Lingeman,et al.  Nephrolithiasis Clinical Guidelines Panel summary report on the management of staghorn calculi. The American Urological Association Nephrolithiasis Clinical Guidelines Panel. , 1994, The Journal of urology.

[264]  Bogdan Nowicki,et al.  Urinary tract infection in pregnant women: Old dogmas and current concepts regarding pathogenesis , 2002, Current infectious disease reports.

[265]  D. Beauchemin,et al.  Unique ability of the Proteus mirabilis capsule to enhance mineral growth in infectious urinary calculi , 1994, Infection and immunity.

[266]  H. Lode,et al.  Pharmacokinetics of ciprofloxacin after oral and parenteral administration , 1985, Antimicrobial Agents and Chemotherapy.

[267]  W. Gaastra,et al.  Nucleotide sequences of two fimbrial major subunit genes, pmpA and ucaA, from canine-uropathogenic Proteus mirabilis strains. , 1995, Microbiology.

[268]  G. Leverson,et al.  Phase 2 clinical trial of a vaginal mucosal vaccine for urinary tract infections. , 2003, The Journal of urology.

[269]  R. Belas,et al.  Transposon mutagenesis in Proteus mirabilis , 1991, Journal of bacteriology.

[270]  P. Zunino,et al.  Evaluation of Proteus mirabilis structural fimbrial proteins as antigens against urinary tract infections. , 2003, FEMS immunology and medical microbiology.

[271]  J. Costerton,et al.  Pseudomonas aeruginosa biofilm as a diffusion barrier to piperacillin , 1992, Antimicrobial Agents and Chemotherapy.

[272]  A. Hartstein,et al.  Nosocomial Urinary Tract Infection: A Prospective Evaluation of 108 Catheterized Patients , 1981, Infection Control.

[273]  A. Plaut The IgA1 proteases of pathogenic bacteria. , 1983, Annual review of microbiology.

[274]  A. Siitonen,et al.  Predominance of class II papG allele of Escherichia coli in pyelonephritis in infants with normal urinary tract anatomy. , 2000, The Journal of infectious diseases.

[275]  F. Keeley,et al.  Evidence for the use of silver-alloy-coated urethral catheters. , 2005, The Journal of hospital infection.

[276]  F. Falkiner The insertion and management of indwelling urethral catheters--minimizing the risk of infection. , 1993, The Journal of hospital infection.

[277]  L. Nicolle A Practical Guide to Antimicrobial Management of Complicated Urinary Tract Infection , 2001, Drugs & aging.

[278]  M. Moeschberger,et al.  The association between the use of urinary catheters and morbidity and mortality among elderly patients in nursing homes. , 1992, American journal of epidemiology.

[279]  L. Sampath,et al.  Evaluation of the Antimicrobial Efficacy of Urinary Catheters Impregnated With Antiseptics in an In Vitro Urinary Tract Model , 2003, Infection Control & Hospital Epidemiology.

[280]  S. Hultgren,et al.  Requirement of Rho‐family GTPases in the invasion of Type 1‐piliated uropathogenic Escherichia coli , 2002, Cellular microbiology.

[281]  Structure of the O-specific polysaccharide of Proteus penneri 71 and classification of cross-reactive P. penneri strains to a new proposed serogroup O64. , 2000, European journal of biochemistry.

[282]  D. Musher,et al.  Do condom catheter collecting systems cause urinary tract infection? , 1979, JAMA.

[283]  R. McLean,et al.  Expression of a nonagglutinating fimbria by Proteus mirabilis , 1995, Infection and immunity.

[284]  A. Jansen,et al.  Mannose-Resistant Proteus-Like Fimbriae Are Produced by Most Proteus mirabilis Strains Infecting the Urinary Tract, Dictate the In Vivo Localization of Bacteria, and Contribute to Biofilm Formation , 2004, Infection and Immunity.

[285]  P. Zunino,et al.  Flagellate and non-flagellate Proteus mirabilis in the development of experimental urinary tract infection. , 1994, Microbial pathogenesis.

[286]  K. Hantke,et al.  The detection of salmochelin and yersiniabactin in uropathogenic Escherichia coli strains by a novel hydrolysis-fluorescence-detection (HFD) method. , 2005, International journal of medical microbiology : IJMM.

[287]  H. Mobley,et al.  Coordinate Expression of Fimbriae in Uropathogenic Escherichia coli , 2005, Infection and Immunity.

[288]  H. C. van der Mei,et al.  Uropathogenic Escherichia coli adhere to urinary catheters without using fimbriae. , 1996, FEMS immunology and medical microbiology.

[289]  D. Koukalová,et al.  [Development of a vaccine for treatment of urinary tract infections]. , 1999, Bratislavske lekarske listy.

[290]  D. MacLaren,et al.  Uropathogenic properties of Proteus mirabilis and Proteus vulgaris. , 1985, Journal of medical microbiology.

[291]  F. Maynard,et al.  A prospective randomized trial of the LoFric hydrophilic coated catheter versus conventional plastic catheter for clean intermittent catheterization. , 2003, The Journal of urology.

[292]  Betsy Foxman,et al.  Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. , 2002, The American journal of medicine.

[293]  J. R. Johnson,et al.  Identification of a New Iron-Regulated Virulence Gene,ireA, in an Extraintestinal Pathogenic Isolate ofEscherichia coli , 2001, Infection and Immunity.

[294]  E. Vinogradov,et al.  Full structure of the O-specific polysaccharide of Proteus mirabilis O24 containing 3,4-O-[(S)-1-carboxyethylidene]-D-galactose. , 2000, Carbohydrate research.

[295]  A. D. Russell,et al.  A strategy for the control of catheter blockage by crystalline Proteus mirabilis biofilm using the antibacterial agent triclosan. , 2005, European urology.

[296]  G. Waksman,et al.  Structural Basis of the Interaction of the Pyelonephritic E. coli Adhesin to Its Human Kidney Receptor , 2001, Cell.

[297]  F. A. Troy,et al.  Polysialylation: from bacteria to brains. , 1992, Glycobiology.

[298]  G. Hirschfield,et al.  Comparison of the Lumac and Monolight systems for detection of bacteriuria by bioluminescence , 1984, Journal of Clinical Microbiology.

[299]  D. Stickler,et al.  Which indwelling urethral catheters resist encrustation by Proteus mirabilis biofilms? , 1997, British journal of urology.

[300]  W. L. Chapman,et al.  Nutritional iron status and susceptibility to Proteus mirabilis pyelonephritis in the rat. , 1982, Canadian journal of microbiology.

[301]  L. Clapham,et al.  The influence of bacteria on struvite crystal habit and its importance in urinary stone formation , 1990 .

[302]  J. Thornby,et al.  Pre-inoculation of urinary catheters with Escherichia coli 83972 inhibits catheter colonization by Enterococcus faecalis. , 2002, The Journal of urology.

[303]  T. Scott THE BACTERIOLOGY OF URINARY INFECTIONS IN PARAPLEGIA , 1960, Journal of clinical pathology.

[304]  D. Stickler,et al.  Modulation of crystalline Proteus mirabilis biofilm development on urinary catheters. , 2006, Journal of medical microbiology.

[305]  J M Hughes,et al.  CDC definitions for nosocomial infections, 1988. , 1988, American journal of infection control.

[306]  H. Mobley,et al.  MrpB Functions as the Terminator for Assembly of Proteus mirabilis Mannose-Resistant Proteus-Like Fimbriae , 1998, Infection and Immunity.

[307]  M. Bailey,et al.  Requirement for FlhA in flagella assembly and swarm‐cell differentiation by Proteus mirabilis , 1995, Molecular microbiology.

[308]  H. Mobley,et al.  Urease activity of Proteus penneri , 1987, Journal of clinical microbiology.

[309]  S J Stahl,et al.  Extracellular slime associated with Proteus mirabilis during swarming. , 1983, Journal of bacteriology.

[310]  A. O’Brien,et al.  Cytotoxic Necrotizing Factor Type 1 of Uropathogenic Escherichia coli Kills Cultured Human Uroepithelial 5637 Cells by an Apoptotic Mechanism , 2000, Infection and Immunity.

[311]  H. Hahn,et al.  The type-4 pilus is the major virulence-associated adhesin of Pseudomonas aeruginosa--a review. , 1997, Gene.

[312]  P. Tambyah,et al.  Catheter-associated urinary tract infection is rarely symptomatic: a prospective study of 1,497 catheterized patients. , 2000, Archives of internal medicine.

[313]  S. E. Jorgensen,et al.  Studies on the origin of the alpha-haemolysin produced by Escherichia coli. , 1976, Journal of medical microbiology.

[314]  L. Nicolle,et al.  Management of Complicated Urinary Tract Infection in Older Patients , 1996, Journal of the American Geriatrics Society.

[315]  Michael J. Long,et al.  An electrified catheter to resist encrustation by Proteus mirabilis biofilm. , 2005, The Journal of urology.

[316]  A. Hodari,et al.  Trocar suprapubic cystostomy for postoperative bladder drainage in the female. , 1966, American journal of obstetrics and gynecology.

[317]  G. Donelli,et al.  Cytotoxic necrotizing factor production by hemolytic strains of Escherichia coli causing extraintestinal infections , 1987, Journal of clinical microbiology.

[318]  D. Watson,et al.  Proteus mirabilis ambient-temperature fimbriae: cloning and nucleotide sequence of the aft gene cluster , 1996, Infection and immunity.

[319]  N. Yakandawala,et al.  Antibiofilm Activity of GlmU Enzyme Inhibitors against Catheter-Associated Uropathogens , 2006, Antimicrobial Agents and Chemotherapy.

[320]  Adrian Russell,et al.  Control of encrustation and blockage of Foley catheters , 2003, The Lancet.

[321]  H. Holthöfer,et al.  Tissue-binding affinity of Proteus mirabilis fimbriae in the human urinary tract , 1990, Infection and immunity.

[322]  R. Selvarangan,et al.  Family of Escherichia coli Dr adhesins: decay-accelerating factor receptor recognition and invasiveness. , 2001, The Journal of infectious diseases.

[323]  R. Belas,et al.  Swarming and pathogenicity of Proteus mirabilis in the urinary tract. , 1995, Trends in microbiology.

[324]  M. Viñas,et al.  New fimbrial adhesins of Serratia marcescens isolated from urinary tract infections: description and properties. , 1997, The Journal of urology.

[325]  S. Hultgren,et al.  Intracellular bacterial communities of uropathogenic Escherichia coli in urinary tract pathogenesis. , 2004, Trends in microbiology.

[326]  W. Feast,et al.  Observations on the adherence of Proteus mirabilis onto polymer surfaces , 2006, Journal of applied microbiology.

[327]  S. Hultgren,et al.  Intracellular Bacterial Biofilm-Like Pods in Urinary Tract Infections , 2003, Science.

[328]  M. Schembri,et al.  Biofilm Formation in a Hydrodynamic Environment by Novel FimH Variants and Ramifications for Virulence , 2001, Infection and Immunity.

[329]  A. Conway,et al.  Activity of a nitrofurazone matrix urinary catheter against catheter-associated uropathogens , 1993, Antimicrobial Agents and Chemotherapy.

[330]  C. Kunin Can we build a better urinary catheter? , 1988, The New England journal of medicine.

[331]  J W Warren,et al.  Catheter-associated urinary tract infections. , 2012, Critical care nurse.

[332]  P. Tambyah,et al.  The relationship between pyuria and infection in patients with indwelling urinary catheters: a prospective study of 761 patients. , 2000, Archives of internal medicine.

[333]  M. Siroky Pathogenesis of bacteriuria and infection in the spinal cord injured patient. , 2002, The American journal of medicine.

[334]  S. Arend,et al.  Is there evidence for recommending silver-coated urinary catheters in guidelines? , 2002, The Journal of hospital infection.

[335]  S. Tasker,et al.  Bergey’s Manual of Systematic Bacteriology , 2010 .

[336]  V. Gant,et al.  Interactions of lactoferricin-derived peptides with LPS and antimicrobial activity. , 2004, FEMS microbiology letters.

[337]  C. Murphy,et al.  Genomic rearrangements in the flagellin genes of Proteus mirabilis , 1999, Molecular microbiology.

[338]  P. Larsson 6 Serology of Proteus mirabilis and Proteus vulgaris , 1984 .

[339]  P. Stewart New ways to stop biofilm infections , 2003, The Lancet.

[340]  P. Stączek,et al.  Cell-free and cell-bound hemolytic activities of Proteus penneri determined by different Hly determinants. , 1991, Canadian journal of microbiology.

[341]  D. Alling,et al.  Prevention of catheter-associated urinary tract infections. Efficacy of daily meatal care regimens. , 1981, The American journal of medicine.

[342]  S. Walz,et al.  Multiple proteins encoded within the urease gene complex of Proteus mirabilis , 1988, Journal of bacteriology.

[343]  S. Hultgren,et al.  Bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[344]  G. Bartsch,et al.  An Escherichia coli-based oral vaccine against urinary tract infections potently activates human dendritic cells. , 2002, Urology.

[345]  P. Freestone,et al.  Stimulation of Staphylococcus epidermidis growth and biofilm formation by catecholamine inotropes , 2003, The Lancet.

[346]  S. Abraham,et al.  Type 1 fimbriated Escherichia coli-mast cell interactions in cystitis. , 2001, The Journal of infectious diseases.

[347]  R. Glockshuber,et al.  Uroplakin Ia is the urothelial receptor for uropathogenic Escherichia coli: evidence from in vitro FimH binding. , 2001, Journal of cell science.

[348]  R. Welch,et al.  The HpmA hemolysin is more common than HlyA among Proteus isolates , 1990, Infection and immunity.

[349]  D. Griffith,et al.  Treatment options in struvite stones. , 1997, The Urologic clinics of North America.

[350]  S. Saint,et al.  Are physicians aware of which of their patients have indwelling urinary catheters? , 2000, The American journal of medicine.

[351]  D. Hooper,et al.  Fluoroquinolone antimicrobial agents. , 1991, Clinical microbiology reviews.

[352]  H. Mobley,et al.  Pathogenesis of Proteus mirabilis urinary tract infection. , 2000, Microbes and infection.

[353]  W. Jarvis,et al.  Selected Aspects of the Socioeconomic Impact of Nosocomial Infections: Morbidity, Mortality, Cost, and Prevention , 1996, Infection Control & Hospital Epidemiology.

[354]  H. Mobley,et al.  Identification of Sat, an autotransporter toxin produced by uropathogenic Escherichia coli , 2000, Molecular microbiology.

[355]  E. Vinogradov,et al.  Structural Study of O-Specific Polysaccharides of Proteus , 1993 .

[356]  D. Rasko,et al.  Autotransporter Genes pic and tsh Are Associated with Escherichia coli Strains That Cause Acute Pyelonephritis and Are Expressed during Urinary Tract Infection , 2004, Infection and Immunity.

[357]  A. Schaeffer,et al.  Current concepts in urinary tract infections. , 2004, Minerva urologica e nefrologica = The Italian journal of urology and nephrology.

[358]  S. Saint,et al.  Biofilms and catheter-associated urinary tract infections. , 2003, Infectious disease clinics of North America.

[359]  R. Freter,et al.  Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin , 1983, Infection and immunity.

[360]  R. Adegbola,et al.  Multiple fimbrial haemagglutinins inSerratia species , 2005, Medical Microbiology and Immunology.

[361]  V. Holers,et al.  Epithelial secretion of C3 promotes colonization of the upper urinary tract by Escherichia coli , 2001, Nature Medicine.

[362]  H. Mobley,et al.  Proteus mirabilis MR/P fimbriae: molecular cloning, expression, and nucleotide sequence of the major fimbrial subunit gene , 1993, Journal of bacteriology.

[363]  J. Oliver,et al.  Role of iron in the pathogenesis of Vibrio vulnificus infections , 1981, Infection and immunity.

[364]  J. Fabry,et al.  Randomized multi-centre trial of the effects of a catheter coated with hydrogel and silver salts on the incidence of hospital-acquired urinary tract infections. , 2000, The Journal of hospital infection.

[365]  Z. Sidorczyk,et al.  Studies on lipopolysaccharides of Proteus vulgaris serogroups. Chemotypes of genus Proteus lipopolysaccharides. , 1975, Bulletin de l'Academie polonaise des sciences. Serie des sciences biologiques.

[366]  A. Plaut Microbial IgA proteases. , 1978, The New England journal of medicine.

[367]  D. Newman Managing indwelling urethral catheters. , 1998, Ostomy/wound management.

[368]  Z. Sidorczyk,et al.  Potential virulence factors of Proteus bacilli. , 1997, Microbiology and molecular biology reviews : MMBR.

[369]  D. Stickler,et al.  The migration of Proteus mirabilis and other urinary tract pathogens over Foley catheters , 2002, BJU international.

[370]  R. Belas,et al.  ZapA, the IgA‐degrading metalloprotease of Proteus mirabilis, is a virulence factor expressed specifically in swarmer cells , 1999, Molecular microbiology.

[371]  F. Duong,et al.  Sequence of a cluster of genes controlling synthesis and secretion of alkaline protease in Pseudomonas aeruginosa: relationships to other secretory pathways. , 1992, Gene.

[372]  A. Iravani Advances in the understanding and treatment of urinary tract infections in young women. , 1991, Urology.

[373]  I. Blomfield,et al.  In vivo phase variation of MR/P fimbrial gene expression in Proteus mirabilis infecting the urinary tract , 1997, Molecular microbiology.

[374]  A. N. Kondakova,et al.  Structure and serological characterization of the O-antigen of Proteus mirabilis O18 with a phosphocholine-containing oligosaccharide phosphate repeating unit. , 2003, Carbohydrate research.

[375]  J. Costerton,et al.  Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms , 2002, Clinical Microbiology Reviews.

[376]  M. Burdick,et al.  Neutrophil recruitment and resistance to urinary tract infection. , 1999, The Journal of infectious diseases.

[377]  G. Shand,et al.  In vivo evidence that bacteria in urinary tract infection grow under iron-restricted conditions , 1985, Infection and immunity.

[378]  R. Belas,et al.  The Genera Proteus, Providencia, and Morganella , 2006 .

[379]  S. Krajden,et al.  Proteus penneri and urinary calculi formation , 1984, Journal of clinical microbiology.

[380]  黄亚明 eMedicine , 2009 .

[381]  J. Mcghee,et al.  Difference in susceptibility to gram-negative urinary tract infection between C3H/HeJ and C3H/HeN mice , 1984, Infection and immunity.

[382]  C. Svanborg,et al.  Epithelial cytokine responses and mucosal cytokine networks. , 1995, Trends in microbiology.

[383]  G. Wilding,et al.  TheSiderophore Receptor IroN of Extraintestinal PathogenicEscherichia coli Is a Potential VaccineCandidate , 2003, Infection and Immunity.

[384]  E. Vinogradov,et al.  Structure of Proteus mirabilis O27 O-specific polysaccharide containing amino acids and phosphoethanolamine. , 1989, European journal of biochemistry.

[385]  B. Yangco,et al.  CDC definitions for nosocomial infections. , 1989, American journal of infection control.

[386]  H. Mobley,et al.  Genetic and biochemical diversity of ureases of Proteus, Providencia, and Morganella species isolated from urinary tract infection , 1987, Infection and immunity.

[387]  W. Ko,et al.  Decreased predominance of papG class II allele in Escherichia coli strains isolated from adults with acute pyelonephritis and urinary tract abnormalities. , 2001, The Journal of urology.

[388]  D. Maskell,et al.  Proteus mirabilis fimbriae (PMF) are important for both bladder and kidney colonization in mice. , 2003, Microbiology.

[389]  Kelly J. Wright,et al.  Development of intracellular bacterial communities of uropathogenic Escherichia coli depends on type 1 pili , 2007, Cellular microbiology.

[390]  M. Waters,et al.  A clinical assessment of the performance of a sensor to detect crystalline biofilm formation on indwelling bladder catheters , 2006, BJU international.

[391]  Kelly J. Wright,et al.  Uropathogenic Escherichia coli Flagella Aid in Efficient Urinary Tract Colonization , 2005, Infection and Immunity.

[392]  N. Khardori,et al.  Modulation of biofilms of Pseudomonas aeruginosa by quinolones , 1995, Antimicrobial agents and chemotherapy.

[393]  A. N. Kondakova,et al.  Structural and serological studies of the O-antigen of Proteus mirabilis O-9. , 2003, Carbohydrate research.

[394]  J. Tenney,et al.  Expression of type 1 fimbriae may be required for persistence of Escherichia coli in the catheterized urinary tract , 1987, Journal of clinical microbiology.

[395]  D. MacLaren,et al.  Investigation of the haemolytic activity of Proteus mirabilis strains , 1983, Antonie van Leeuwenhoek.

[396]  S. Hultgren,et al.  Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. , 1998, Science.

[397]  C. Svanborg,et al.  Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[398]  R. Kolter,et al.  Exopolysaccharide Production Is Required for Development of Escherichia coli K-12 Biofilm Architecture , 2000, Journal of bacteriology.

[399]  J. Preston,et al.  The pgaABCD Locus of Escherichia coli Promotes the Synthesis of a Polysaccharide Adhesin Required for Biofilm Formation , 2004, Journal of bacteriology.

[400]  M. Gelman Antibiotic irrigation and catheter-associated urinary tract infections. , 1980, Nephron.

[401]  S. Krajden,et al.  Expanded clinical spectrum of infections caused by Proteus penneri , 1987, Journal of clinical microbiology.

[402]  D. Stickler,et al.  Encrustation of indwelling urethral catheters by Proteus mirabilis biofilms growing in human urine. , 1998, The Journal of hospital infection.

[403]  A. Siitonen,et al.  Variations in 10 putative uropathogen virulence genes among urinary, faecal and peri-urethral Escherichia coli. , 2002, Journal of medical microbiology.

[404]  R. Belas,et al.  Molecular analysis of a metalloprotease from Proteus mirabilis , 1995, Journal of bacteriology.

[405]  Thomas P. Minka,et al.  Gates , 2008, NIPS.

[406]  R. Chaitow Guideline for prevention of catheter-associated urinary tract infections. , 1981, Infection control : IC.

[407]  R. Kolter,et al.  [2] Biofilm formation as a developmental process , 2001 .

[408]  P. Rather,et al.  Evidence that putrescine acts as an extracellular signal required for swarming in Proteus mirabilis , 2004, Molecular microbiology.

[409]  J. Heesemann,et al.  Characterization of an iroBCDEN Gene Cluster on a Transmissible Plasmid of Uropathogenic Escherichia coli: Evidence for Horizontal Transfer of a Chromosomal Virulence Factor , 2003, Infection and Immunity.

[410]  C. Tang,et al.  Type 1 fimbriae and extracellular polysaccharides are preeminent uropathogenic Escherichia coli virulence determinants in the murine urinary tract , 2002, Molecular microbiology.

[411]  M. Meng,et al.  Infections and urinary stone disease. , 2003, Current pharmaceutical design.

[412]  M. Loeb,et al.  Why are antibiotics prescribed for asymptomatic bacteriuria in institutionalized elderly people? A qualitative study of physicians' and nurses' perceptions. , 2000, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[413]  S. Clegg,et al.  Enterobacterial fimbriae , 1987, Journal of bacteriology.

[414]  T. Dawson,et al.  37-kDa Laminin Receptor Precursor Modulates Cytotoxic Necrotizing Factor 1–mediated RhoA Activation and Bacterial Uptake* , 2003, The Journal of Biological Chemistry.

[415]  D. Old,et al.  The haemagglutinins and fimbriae of Proteus penneri. , 1989, Journal of medical microbiology.

[416]  James R. Johnson Microbial virulence determinants and the pathogenesis of urinary tract infection. , 2003, Infectious disease clinics of North America.

[417]  J. Neilands,et al.  Molecular mechanism of regulation of siderophore-mediated iron assimilation. , 1987, Microbiological reviews.

[418]  A. Schaeffer Types of urethral catheters for management of short-term voiding problems in hospitalised adults. , 2005, The Journal of urology.

[419]  G. Jung,et al.  Alpha-keto acids are novel siderophores in the genera Proteus, Providencia, and Morganella and are produced by amino acid deaminases , 1993, Journal of bacteriology.

[420]  K. Krogfelt,et al.  Capsule and Fimbria Interaction in Klebsiella pneumoniae , 2005, Infection and Immunity.

[421]  G. Reid,et al.  Can bacterial interference prevent infection? , 2001, Trends in microbiology.

[422]  Ankur H. Shah,et al.  Localization of a domain in the FimH adhesin of Escherichia coli type 1 fimbriae capable of receptor recognition and use of a domain-specific antibody to confer protection against experimental urinary tract infection. , 1997, The Journal of clinical investigation.

[423]  Viktoria Hancock,et al.  Specific selection for virulent urinary tract infectious Escherichia coli strains during catheter-associated biofilm formation. , 2007, FEMS immunology and medical microbiology.

[424]  Public health focus: surveillance, prevention, and control of nosocomial infections. , 1992, MMWR. Morbidity and mortality weekly report.

[425]  C. Fiorentini,et al.  Escherichia coli Cytotoxic Necrotizing Factor 1 Blocks Cell Cycle G2/M Transition in Uroepithelial Cells , 2006, Infection and Immunity.

[426]  M. Kerr,et al.  Proteinases of Proteus spp.: purification, properties, and detection in urine of infected patients , 1992, Infection and immunity.

[427]  A. O’Brien,et al.  Cytotoxic Necrotizing Factor Type 1 Production by Uropathogenic Escherichia coli Modulates Polymorphonuclear Leukocyte Function , 2005, Infection and Immunity.

[428]  C. Pederzolli,et al.  Permeability Increase Induced by Escherichia coli Hemolysin A in Human Macrophages is Due to the Formation of Ionic Pores: A Patch Clamp Characterization , 1996, The Journal of Membrane Biology.

[429]  B. Senior,et al.  Rare occurrence of Proteus vulgaris in faeces: a reason for its rare association with urinary tract infections. , 1986, Journal of medical microbiology.

[430]  W. Stamm Catheter-associated urinary tract infections: epidemiology, pathogenesis, and prevention. , 1991, The American journal of medicine.

[431]  H. Mobley,et al.  Proteus mirabilis urease: transcriptional regulation by UreR , 1993, Journal of bacteriology.

[432]  H. Mobley,et al.  Proteus mirabilis fimbriae: construction of an isogenic pmfA mutant and analysis of virulence in a CBA mouse model of ascending urinary tract infection , 1994, Infection and immunity.

[433]  J. Beizer Urinary incontinence in women: a review for the pharmacist. , 1996, Journal of the American Pharmaceutical Association.

[434]  M. Rohde,et al.  The multicellular morphotypes of Salmonella typhimurium and Escherichia coli produce cellulose as the second component of the extracellular matrix , 2001, Molecular microbiology.

[435]  P. Larsson,et al.  0 antigen distribution and sensitivity to the bactericidal effect of normal human serum ofProteus strains from clinical specimens , 1977, Medical Microbiology and Immunology.

[436]  J. Pinkner,et al.  STRUCTURAL BASIS OF THE INTERACTION OF THE PYELONEPHRITIC E. , 2001 .

[437]  Scott J. Hultgren,et al.  Bacterial Adhesins: Common Themes and Variations in Architecture and Assembly , 1999, Journal of bacteriology.

[438]  G. Reid,et al.  The effect of protein and urine on uropathogen adhesion to polymer substrata. , 1990, Journal of biomedical materials research.

[439]  J. Hacker,et al.  Binding of Escherichia coli S fimbriae to human kidney epithelium , 1986, Infection and immunity.

[440]  R. Belas,et al.  Proteus mirabilis mutants defective in swarmer cell differentiation and multicellular behavior , 1991, Journal of bacteriology.

[441]  S. Kadis,et al.  Siderophore production by Proteus mirabilis. , 1984, Canadian journal of microbiology.

[442]  Y. Knirel,et al.  Structural and serological studies on the O-antigen of Proteus mirabilis O14, a new polysaccharide containing 2-[(R)-1-carboxyethylamino]ethyl phosphate. , 1999, European journal of biochemistry.

[443]  P Mullany,et al.  Transfer of a conjugative transposon, Tn5397 in a model oral biofilm. , 1999, FEMS microbiology letters.

[444]  C. Deighton,et al.  Anti-Proteus antibodies in rheumatoid arthritis same-sexed sibships. , 1992, British journal of rheumatology.

[445]  M. Emberton,et al.  Catheter‐associated urinary tract infections: prevalence of uropathogens and pattern of antimicrobial resistance in a UK hospital (1996–2001) , 2003, BJU international.

[446]  T. Knoll,et al.  [Pathophysiology, diagnosis and conservative therapy of non-calcium kidney calculi]. , 2003, Therapeutische Umschau. Revue therapeutique.

[447]  K. Zych,et al.  Lipopolysaccharides of Proteus penneri species novum. , 1989, Carbohydrate research.

[448]  H. Mobley,et al.  Development of an Intranasal Vaccine To Prevent Urinary Tract Infection by Proteus mirabilis , 2004, Infection and Immunity.

[449]  R. Selvarangan,et al.  Dr fimbriae operon of uropathogenic Escherichia coli mediate microtubule-dependent invasion to the HeLa epithelial cell line. , 1997, The Journal of infectious diseases.

[450]  H. Lai,et al.  A cell‐surface polysaccharide that facilitates rapid population migration by differentiated swarm cells of Proteus mirabilis , 1995, Molecular microbiology.

[451]  M. Priebe,et al.  Limited vs full microbiological investigation for the management of symptomatic polymicrobial urinary tract infection in adult spinal cord-injured patients , 1997, Spinal Cord.

[452]  A. Ebringer,et al.  Rheumatoid arthritis and proteus: a possible aetiological association , 2004, Rheumatology International.

[453]  T. Yamamoto,et al.  Fimbria‐Mediated Adherence of Serratia marcescens Strain US5 to Human Urinary Bladder Surface , 1985, Microbiology and immunology.

[454]  V. Koronakis,et al.  Identification of the promoters directing in vivo expression of hemolysin genes in Proteus vulgaris and Escherichia coli. , 1988, Molecular & general genetics : MGG.

[455]  Y. Knirel,et al.  Structure of the O-polysaccharide and classification of Proteus mirabilis strain G1 in Proteus serogroup O3. , 2002, European journal of biochemistry.

[456]  L. A. Fernández,et al.  Secretion and assembly of regular surface structures in Gram-negative bacteria. , 2000, FEMS microbiology reviews.

[457]  R. Welch,et al.  Nucleotide sequencing of the Proteus mirabilis calcium-independent hemolysin genes (hpmA and hpmB) reveals sequence similarity with the Serratia marcescens hemolysin genes (shlA and shlB) , 1990, Journal of bacteriology.